Revere Partners
Overview
The first independent venture capital fund exclusively focused on oral health, identifying opportunities for investors and providing capital for cutting-edge technology innovations in the oral and systemic health sectors. The firm primarily focuses on investing in Seed and Series A rounds and operates as an AngelList Rolling Fund.
Portfolio Companies
5
Website
reverepartners.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Toothio | Oct 2024 | Seed | Co-investor |
| Peerlogic | Jan 2024 | Seed | Co-investor |
| Plan Forward | Oct 2023 | Seed | Co-investor |
| Augmedit | Nov 2022 | Seed | Co-investor |
| Zuub | Jan 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Revere Partners based?
Revere Partners is headquartered in New York City, New York, United States.
When was Revere Partners founded?
Founding year information for Revere Partners is not publicly available.
How many portfolio companies does Revere Partners have?
Revere Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in Revere Partners's portfolio?
Portfolio companies visible on Caplight include Toothio, Peerlogic, Plan Forward, Augmedit, Zuub.
What was Revere Partners's most recent investment shown here?
Revere Partners's most recent investment in this portfolio sample was in Toothio in 2024.
What sectors does Revere Partners focus on?
Revere Partners focuses on Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Healthcare & Life Sciences.
What company stages does Revere Partners focus on?
Revere Partners typically invests at the Early stage.